
KD025m1 is a novel селективный ROCK2 ингибитор. KD025m1 has good anti obesity, improved insulin sensitivity, and blood glucose control effects. KD025m1 can be used to study metabolic diseases such as diabetes and obesity.
KD025m1 is a novel selective ROCK2 inhibitor. KD025m1 has good anti obesity, improved insulin sensitivity, and blood glucose control effects. KD025m1 can be used to study metabolic diseases such as diabetes and obesity.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.